USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Raysearch Laboratories AB (publ)

USPTO PatentsView assignee record - 20 granted patents across 8 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

20
Total patents granted
8
CPC technology areas
13.8
Avg claims per patent
-
5-year filing velocity

The verdict

Raysearch holds 20 US patents across 8 technology areas, rank #14,889 of 50,000 tracked assignees.

#14,889
of 50,000 US assignees by volume
Top 16%
by Innovation Score (48.8/100)
13.8
avg claims per patent

Portfolio overview

Raysearch Laboratories AB (publ) has been granted 20 US utility patents between 2022 and 2025, placing Raysearch Laboratories AB (publ) at rank #14,889 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.8 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a Foreign Corporation, Raysearch Laboratories AB (publ) is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 48.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 20 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Raysearch Laboratories AB (publ)'s 13.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Raysearch Laboratories AB (publ) against peers pursuing similar technology classes.

How does Raysearch compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows Raysearch holds 20 patents, placing it at rank #14,889 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Raysearch's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

0246810 2022202320242025 7
USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
Raysearch Laboratories AB (publ) patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 1 5.0%
2023 3 15.0%
2024 9 45.0%
2025 7 35.0%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard

Where it ranks

Overall rank by patents

#14,889

Across all tracked assignees

Innovation Score

48.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Raysearch Laboratories AB (publ) hold?
Raysearch Laboratories AB (publ) holds 20 US granted patents filed between 2022 and 2025, spanning 8 technology areas.
What is Raysearch Laboratories AB (publ)'s Innovation Score?
Raysearch Laboratories AB (publ) has an Innovation Score of 48.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Raysearch Laboratories AB (publ) focus on?
Raysearch Laboratories AB (publ)'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 19 patents. The company has filed patents in 8 CPC subclasses total.
Is Raysearch Laboratories AB (publ)'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Raysearch Laboratories AB (publ).
What does claim depth mean for Raysearch Laboratories AB (publ)'s patents?
Raysearch Laboratories AB (publ)'s patents average 13.8 claims each. This falls within the standard range, providing solid legal coverage.
How is the Raysearch Laboratories AB (publ) patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Guides to patent portfolio analysis

How to use this portfolio

Raysearch's 20 grants land it in the top 16% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Raysearch ranks #14,889 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61N - see who else leads that technology area. A61N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov